Association of Patient Cost Sharing With Adherence to GLP-1RA and Adverse Health Outcomes
Higher OOP costs for GLP-1RA were associated with reduced adherence and increased rates of adverse outcomes among patients with type 2 diabetes.
Authors
- Nihan Gencerliler (ORCID: https://orcid.org/0000-0002-8269-5437)
- Vivian Hsing-Chun Wang (ORCID: https://orcid.org/0000-0002-5638-204X)
- Morgan E. Grams (ORCID: https://orcid.org/0000-0002-4430-6023)
- Donglan Zhang (ORCID: https://orcid.org/0000-0001-5225-4721)
- Jung‐Im Shin (ORCID: https://orcid.org/0000-0003-0374-6927)
- Karan R. Chhabra (ORCID: https://orcid.org/0000-0001-6620-8777)
- Anand Prem Rajan (ORCID: https://orcid.org/0000-0001-5659-0386)
- Amrita Mukhopadhyay (ORCID: https://orcid.org/0000-0002-7768-459X)
- Yunwen Xu (ORCID: https://orcid.org/0000-0002-5946-2272)
- Davene R. Wright (ORCID: https://orcid.org/0000-0002-8574-4572)
- Saul Blecker (ORCID: https://orcid.org/0000-0003-4460-1046)
- Jasmin Divers
- E. M. Butt
Institutions
- New York City Health and Hospitals Corporation (US)
- Harvard University (US)
- Long Island University (US)
- Johns Hopkins University (US)
- Bellevue Hospital Center (US)
- Harvard Pilgrim Health Care (US)
- New York University (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-04-09
- DOI
- https://doi.org/10.2337/dc24-2746
- Citations
- 9
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 28.18